Back

Select your region

Corporate

europe:

Flag Albania Albania Flag Bosnia and Herzegovina Bosnia and Herzegovina Flag Bulgaria Bulgaria Flag Croatia Croatia Flag Cyprus Cyprus Flag Montenegro Montenegro Flag Czech Republic Czech Republic Flag Denmark Denmark Flag Estonia Estonia Flag Spain Spain Flag Kosovo Kosovo Flag Lithuania Lithuania Flag Latvia Latvia Flag Luxembourg Luxembourg Flag Macedonia Macedonia Flag Germany Germany Flag Poland Poland Flag Portugal Portugal Flag Romania Romania Flag Serbia Serbia Flag Slovakia Slovakia Flag Slovenia Slovenia Flag Switzerland Switzerland Flag Sweden Sweden Flag Turkey Turkey Flag Hungary Hungary Flag United Kingdom United Kingdom Flag Italy Italy

Asia:

Flag UAE UAE Flag Hong Kong Hong Kong Flag Kuwait Kuwait Flag Lebanon Lebanon

Africa:

Flag South Africa South Africa

Schedule a cord blood consultation

Make an appointment

Contact us today!

Want to learn more about our services? Complete the form below and we will contact you as soon as possible to provide you with all the information you need and answer your questions.

    We kindly inform you that the personal data provided in the form will be processed by Polski Bank Komórek Macierzystych Sp. z o.o. ("PBKM") with its registered office in Warsaw, Al. Jana Pawła II 29 for telephone contact in connection with the provision of information on the service.

    Summary of patients treated

    Stem Cells
    Therapies

    Stem Cells Therapies

    The purpose of banking stem cells is to apply them in the therapy. For the first time cord blood was used in 1988 and since then according to publicly available statistics it has been used over 85 000 times worldwide (including statistics of China).

    FamiCord Group stores over 1,000,000 samples of cells of different types and has supplied stem cells for application in clinic for more than 7000 patients. We supply stem cells for standard transplantations (cord blood , bone marrow and mobilized peripheral blood) and cellular therapies. On top of that we provide cell based products in GMP standard for clinical trials.

    Stem cells manufactured in our premises helped patients with various diseases and therapeutic areas, including haematological, neurological, ophthalmological, orthopaedical, dermatological disorders.

    Check the full list of patients who received stem cell therapy derived from FamiCord labs.

    List last update: 06.2026

    List of patients who received stem cells from FamiCord Group laboratories

    List of patients who received stem cells from FamiCord Group laboratories
    Lp. Source Source type Diagnosis Medical field Year of application Therapy Country Age of recipient
    3201 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 62
    3202 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 63
    3203 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 71
    3204 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 72
    3205 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 33
    3206 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 3
    3207 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 65
    3208 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 16
    3209 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 66
    3210 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 64
    3211 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 71
    3212 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 62
    3213 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 48
    3214 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 62
    3215 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 48
    3216 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 73
    3217 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 69
    3218 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 79
    3219 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 54
    3220 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 44
    3221 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 63
    3222 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 56
    3223 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 65
    3224 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 72
    3225 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 65
    3226 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 64
    3227 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 65
    3228 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 70
    3229 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 66
    3230 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 88
    3231 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 67
    3232 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 52
    3233 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 57
    3234 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 62
    3235 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 36
    3236 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 61
    3237 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 11
    3238 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Germany 61
    3239 Apheresis Allogeneic Myelodysplastic Syndrome – Raeb2 Hematology 2022 Standard Therapy Poland 62
    3240 Apheresis Allogeneic Myelodysplastic Syndrome Rc Hematology 2022 Standard Therapy Poland 3
    3241 Apheresis Allogeneic Myelodysplastic Syndrome With Excess Blasts 1 Hematology 2022 Standard Therapy Poland 59
    3242 Apheresis Allogeneic Myelodysplastic Syndrome With Excess Blasts 2 Hematology 2022 Standard Therapy Poland 67
    3243 Apheresis Allogeneic Myelodysplastic Syndrome With Fibrosis Hematology 2022 Standard Therapy Poland 72
    3244 Apheresis Allogeneic Myelofibrosis Hematology 2022 Standard Therapy Poland 58
    3245 Apheresis Allogeneic Myelofibrosis Hematology 2022 Standard Therapy Poland 69
    3246 Apheresis Allogeneic Myelofibrosis Hematology 2022 Standard Therapy Poland 57
    3247 Apheresis Allogeneic Myelofibrosis Hematology 2022 Standard Therapy Poland 64
    3248 Apheresis Allogeneic Myelofibrosis Hematology 2022 Standard Therapy Poland 73
    3249 Apheresis Allogeneic Myelofibrosis Hematology 2022 Standard Therapy Poland 67
    3250 Apheresis Allogeneic Myelofibrosis Hematology 2022 Standard Therapy Poland 66
    3251 Apheresis Allogeneic Myelofibrosis Hematology 2022 Standard Therapy Poland 69
    3252 Apheresis Allogeneic Myelofibrosis Hematology 2022 Standard Therapy Poland 60
    3253 Apheresis Allogeneic Myelofibrosis Myeloid Metaplasia Hematology 2022 Standard Therapy Poland 69
    3254 Apheresis Allogeneic Myelofibrosis Post Essential Thrombocythemia Hematology 2022 Standard Therapy Poland 64
    3255 Apheresis Allogeneic Myelofibrosis With Myeloid Metaplasia Hematology 2022 Standard Therapy Poland 58
    3256 Apheresis Allogeneic Myelofibrosis With Myeloid Metaplasia Hematology 2022 Standard Therapy Poland 72
    3257 Apheresis Allogeneic Myelofibrosis With Myeloid Metaplasia Hematology 2022 Standard Therapy Poland 73
    3258 Apheresis Autologous Myeloma Hematology 2022 Standard Therapy Germany 54
    3259 Apheresis Allogeneic Myeloma Multiplex Hematology 2022 Standard Therapy Poland 31
    3260 Apheresis Allogeneic Myeloproliferative Neoplasms With Acute Myeloid Leukemia Hematology 2022 Standard Therapy Germany 59
    3261 Apheresis Allogeneic No Data Hematology 2022 Standard Therapy Poland 50
    3262 Apheresis Allogeneic No Data Hematology 2022 Standard Therapy Poland 37
    3263 Apheresis Allogeneic No Data Hematology 2022 Standard Therapy Poland 64
    3264 Apheresis Allogeneic No Data Hematology 2022 Standard Therapy Poland 59
    3265 Apheresis Allogeneic No Data Hematology 2022 Standard Therapy Poland 21
    3266 Apheresis Allogeneic No Data Hematology 2022 Standard Therapy Poland 38
    3267 Apheresis Autologous Nodular Lymphocyte Predominant Hodgkin Lymphoma Hematology 2022 Standard Therapy Germany 31
    3268 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2022 Standard Therapy Poland 73
    3269 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2022 Standard Therapy Poland 61
    3270 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2022 Standard Therapy Poland 53
    3271 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2022 Standard Therapy Poland 18
    3272 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2022 Standard Therapy Poland 28
    3273 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2022 Standard Therapy Poland 55
    3274 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2022 Standard Therapy Poland 59
    3275 Apheresis Autologous Non-Hodgkin Lymphoma Hematology 2022 Standard Therapy Germany 52
    3276 Apheresis Allogeneic Osteomyelofibrosis Hematology 2022 Standard Therapy Poland 59
    3277 Apheresis Allogeneic Osteomyelofibrosis Hematology 2022 Standard Therapy Poland 59
    3278 Apheresis Allogeneic Other Immune System Hematology 2022 Standard Therapy Poland 46
    3279 Apheresis Allogeneic Other Malignancy Hematology 2022 Standard Therapy Poland 72
    3280 Apheresis Allogeneic Peripheral T-Cell Lymphoma Hematology 2022 Standard Therapy Poland 32
    3281 Apheresis Allogeneic Plasma Cell Disorder Hematology 2022 Standard Therapy Poland 56
    3282 Apheresis Allogeneic Plasma Cell Leukemia Hematology 2022 Standard Therapy Poland 58
    3283 Apheresis Allogeneic Post-Essential Thrombocythemia-Myelofibrosis Hematology 2022 Standard Therapy Poland 64
    3284 Apheresis Allogeneic Post–Polycythemia Vera Myelofibrosis (Post-Pv Mf)  Hematology 2022 Standard Therapy Poland 48
    3285 Apheresis Autologous Primary Central Nervous System Lymphoma Hematology 2022 Standard Therapy Germany 65
    3286 Apheresis Autologous Primary Central Nervous System Lymphoma Hematology 2022 Standard Therapy Germany 65
    3287 Apheresis Autologous Primary Central Nervous System Lymphoma Hematology 2022 Standard Therapy Germany 58
    3288 Apheresis Autologous Primary Central Nervous System Lymphoma Hematology 2022 Standard Therapy Germany 39
    3289 Apheresis Autologous Primary Central Nervous System Lymphoma Hematology 2022 Standard Therapy Germany 67
    3290 Apheresis Autologous Primary Central Nervous System Lymphoma Hematology 2022 Standard Therapy Germany 37
    3291 Apheresis Autologous Primary Central Nervous System Lymphoma Hematology 2022 Standard Therapy Germany 69
    3292 Apheresis Allogeneic Primary Myelofibrosis Hematology 2022 Standard Therapy Poland 62
    3293 Apheresis Allogeneic Primary Myelofibrosis Hematology 2022 Standard Therapy Poland 66
    3294 Apheresis Allogeneic Primary Myelofibrosis Hematology 2022 Standard Therapy Poland 70
    3295 Apheresis Allogeneic Primary Refractory T-Cell Lymphoma Hematology 2022 Standard Therapy Poland 55
    3296 Apheresis Allogeneic Secondary Acute Myeloid Leukemia Hematology 2022 Standard Therapy Poland 58
    3297 Apheresis Allogeneic Secondary Acute Myeloid Leukemia Hematology 2022 Standard Therapy Germany 51
    3298 Apheresis Allogeneic Severe Aplastic Anemia Hematology 2022 Standard Therapy Poland 53
    3299 Apheresis Allogeneic Severe Aplastic Anemia Hematology 2022 Standard Therapy Poland 45
    3300 Apheresis Allogeneic Severe Combined Immunodeficiency Hematology 2022 Standard Therapy Poland 3